tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Amphastar Pharmaceuticals Inc

AMPH
Add to Watchlist
19.940USD
-0.440-2.16%
Close 07-31 16:00（ET）Quotes delayed by 15 min
879.21MMarket Cap
11.66P/E TTM

Amphastar Pharmaceuticals Inc

19.940
-0.440-2.16%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

AMPH Financials

See Amphastar Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Amphastar Pharmaceuticals Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/0.62
Revenue / Forecast
--/182.06M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
719.89M
-1.65%
EPS(YoY)
2.10
-36.29%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-73.31%0.14
-32.75%0.53
-55.10%0.37
-14.82%0.66
-40.74%0.53
4.92%0.79
-17.73%0.83
43.77%0.78
65.13%0.90
7.41%0.75
--1.01
--0.54
--0.54
--0.70
--1.18
----
----
----
----
----
Revenue
0.38%171.17M
-1.83%183.10M
0.33%191.84M
-4.38%174.41M
-0.76%170.53M
4.73%186.52M
5.90%191.21M
25.17%182.39M
22.72%171.84M
31.91%178.10M
50.30%180.56M
18.02%145.71M
16.33%140.02M
11.69%135.02M
7.07%120.13M
21.45%123.47M
16.84%120.37M
26.03%120.89M
34.48%112.20M
18.48%101.66M
Net Profit
-74.61%6.42M
-35.65%24.43M
-57.09%17.35M
-18.23%31.03M
-41.44%25.29M
4.97%37.96M
-17.86%40.43M
45.26%37.95M
65.86%43.18M
6.65%36.17M
210.08%49.22M
50.61%26.12M
7.34%26.03M
71.62%33.91M
-46.28%15.87M
123.33%17.35M
381.11%24.25M
415.00%19.76M
653.97%29.55M
4145.31%7.77M
Net Margin
-74.70%3.75%
-34.45%13.34%
-57.23%9.04%
-14.49%17.79%
-40.99%14.83%
0.23%20.35%
-22.44%21.14%
16.05%20.81%
35.15%25.13%
-19.15%20.31%
--27.26%
--17.93%
--18.59%
--25.12%
--15.79%
----
----
----
----
----
Gross Margin
-17.82%41.08%
0.72%46.79%
-3.55%51.42%
-4.96%49.59%
-4.66%49.99%
-13.94%46.45%
-11.20%53.31%
0.78%52.18%
-0.57%52.43%
2.41%53.98%
--60.04%
--51.77%
--52.73%
--52.71%
--48.82%
----
----
----
----
----
Debt to assets ratio
-0.12%37.10%
-1.81%37.46%
-5.27%36.58%
-4.28%37.68%
-1.62%37.15%
-2.17%38.15%
-6.60%38.62%
8.24%39.36%
289.28%37.76%
281.32%39.00%
--41.35%
--36.36%
--9.70%
--10.23%
--10.42%
----
----
----
----
----
Income Statement
Revenue
0.38%171.17M
-1.83%183.10M
0.33%191.84M
-4.38%174.41M
-0.76%170.53M
4.73%186.52M
5.90%191.21M
25.17%182.39M
22.72%171.84M
31.91%178.10M
50.30%180.56M
18.02%145.71M
16.33%140.02M
11.69%135.02M
7.07%120.13M
21.45%123.47M
16.84%120.37M
26.03%120.89M
34.48%112.20M
18.48%101.66M
Operating profit
-63.45%13.63M
-21.13%35.61M
-55.62%25.32M
-23.60%42.18M
-22.32%37.29M
-16.37%45.14M
-21.51%57.05M
39.45%55.22M
43.60%48.01M
42.68%53.98M
212.89%72.68M
59.51%39.60M
54.68%33.43M
56.00%37.83M
-6.22%23.23M
135.07%24.82M
109.72%21.61M
742.38%24.25M
604.26%24.77M
461.40%10.56M
Net Profit
-74.61%6.42M
-35.65%24.43M
-57.09%17.35M
-18.23%31.03M
-41.44%25.29M
4.97%37.96M
-17.86%40.43M
45.26%37.95M
65.86%43.18M
6.65%36.17M
210.08%49.22M
50.61%26.12M
7.34%26.03M
71.62%33.91M
-46.28%15.87M
123.33%17.35M
381.11%24.25M
415.00%19.76M
653.97%29.55M
4145.31%7.77M
Balance Sheet
Current assets
7.78%633.68M
19.09%636.02M
17.13%639.47M
20.34%580.83M
5.92%587.96M
9.08%534.07M
0.54%545.95M
25.51%482.64M
36.16%555.08M
29.41%489.60M
41.33%543.00M
1.96%384.55M
11.87%407.67M
18.92%378.32M
26.53%384.22M
21.28%377.14M
21.41%364.42M
13.74%318.12M
9.81%303.67M
16.55%310.97M
Total current liabilities
-17.37%164.48M
-8.98%158.16M
29.07%205.23M
28.79%176.41M
-21.99%199.05M
-22.91%173.76M
-38.36%159.01M
-45.49%136.97M
141.56%255.17M
137.62%225.41M
152.43%257.96M
142.47%251.28M
-7.63%105.64M
-8.62%94.86M
4.29%102.19M
-16.79%103.63M
-10.02%114.36M
-7.48%103.81M
1.32%97.99M
33.51%124.55M
Total assets
1.35%1.65B
3.29%1.63B
7.83%1.67B
8.30%1.62B
3.30%1.63B
4.27%1.58B
0.04%1.55B
8.22%1.49B
103.49%1.57B
103.90%1.51B
112.56%1.54B
90.44%1.38B
8.02%773.66M
10.49%741.99M
11.51%726.70M
8.71%723.72M
10.92%716.24M
6.38%671.53M
6.19%651.68M
10.95%665.75M
Total liabilities
-0.03%874.77M
-0.55%840.49M
8.80%889.48M
10.24%857.85M
-2.99%874.99M
-3.24%845.17M
-13.90%817.50M
-1.38%778.18M
300.73%901.96M
309.46%873.49M
328.61%949.49M
251.60%789.03M
-4.91%225.08M
-5.61%213.33M
0.01%221.53M
13.04%224.41M
21.53%236.71M
23.83%226.01M
36.09%221.50M
25.95%198.52M
Total equity
2.94%773.39M
7.72%788.80M
6.74%776.75M
6.19%757.48M
11.74%751.28M
14.53%732.30M
22.27%727.68M
21.06%713.35M
22.56%672.36M
20.95%639.42M
17.81%595.14M
18.01%589.24M
14.40%548.58M
18.66%528.66M
17.43%505.17M
6.87%499.31M
6.33%479.52M
-0.71%445.52M
-4.61%430.18M
5.60%467.22M
Cash Flow Statement
Net operating income
36.39%47.84M
13.23%32.86M
-12.31%52.58M
-48.50%35.59M
-36.56%35.08M
21.62%29.02M
-6.80%59.96M
25.83%69.11M
36.92%55.29M
56.73%23.86M
215.75%64.33M
1851.08%54.92M
-20.45%40.38M
-62.35%15.23M
693.11%20.38M
-91.25%2.81M
122.41%50.77M
139.40%40.44M
-70.83%2.57M
6.88%32.16M
Net investment
-259.65%-16.73M
-69.77%-60.57M
43.27%-19.62M
99.11%-625.00K
-31.21%10.48M
65.38%-35.68M
-11.02%-34.59M
86.26%-69.90M
340.60%15.24M
-44899.56%-103.05M
-104.17%-31.15M
-6117.38%-508.58M
30.48%-6.33M
98.08%-229.00K
-304.83%-15.26M
-92.29%-8.18M
-4.77%-9.11M
1.82%-11.95M
30.86%-3.77M
57.74%-4.25M
Net financing
-108.28%-30.21M
45.71%-18.37M
80.95%-4.35M
-181.84%-30.20M
-6.80%-14.50M
28.12%-33.84M
-126.34%-22.82M
-102.50%-10.72M
-0.23%-13.58M
-191.32%-47.08M
721.73%86.61M
43169.52%428.11M
-391.48%-13.55M
-85.86%-16.16M
15.53%-13.93M
80.85%-994.00K
170.01%4.65M
-3730.84%-8.70M
-445.01%-16.49M
-141.67%-5.19M

FAQs

What is the total revenue of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 719.89M, with a year-on-year change of 731.97M.

What are the current assets of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its current assets were 636.02M, with a year-on-year change of 19.09.

What are the total assets of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its total assets of Amphastar Pharmaceuticals Inc were 1.63B, with a year-on-year change of 3.29.

What are the total liabilities of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Amphastar Pharmaceuticals Inc were 840.49M, with a year-on-year change of -0.55.

What is the total equity of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its total equity of Amphastar Pharmaceuticals Inc was 788.80M, with a year-on-year change of 7.72.

What is the net operating income of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Amphastar Pharmaceuticals Inc was 140.40M, with a year-on-year change of -31.65.

What is the net investment of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its net investment of Amphastar Pharmaceuticals Inc was -70.33M, with a year-on-year change of 43.70.

What is the net financing of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its net financing of Amphastar Pharmaceuticals Inc was -67.42M, with a year-on-year change of 16.71.

What is the Earnings Per Share (EPS) of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 2.10, with a year-on-year change of -36.29.

What is the net income of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its net income was 98.09M, with a year-on-year change of -38.51.

What is the net margin of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 13.63, with a year-on-year change of -37.47.

What is the gross margin of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 49.46, with a year-on-year change of -3.16.

What is the debt-to-asset ratio of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 37.46, with a year-on-year change of -1.81.

What is the Return on Equity (ROE) of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was 12.90, with a year-on-year change of -44.55.

What is the Return on Assets (ROA) of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 6.12, with a year-on-year change of -40.74.

What is the operating profit of Amphastar Pharmaceuticals Inc?

According to Amphastar Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 140.40M, with a year-on-year change of -31.65.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy